语言版本

Time of issue:2021-09-02 16:56:33

中文 English





搜索

Search





Homepage

/

Product

/

API

/

Bendamustine HCl

All categories



Number of views:

1000

Bendamustine HCl

Bendamustine HCl was originally manufactured in East Germany (former German Democratic Republic) in 1963.

Retail price

0.0

元

Market price

0.0

元

Number of views:

1000

No.

Category

API

Chemical Name:

4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid hydrochloride ( or hydrate)

Molecular Formula:

C16H21Cl2N3O2·HCl

Molecular Weight:

394.72

Therapeutic Classification:

Oncology

CAS:

3543-75-7

Registration File:

US-DMF, ASMF, JDMF, KDMF, etc.

Quantity

-

+

Stock:



1

Detail

Parameters

　　Bendamustine HCl was originally manufactured in East Germany (former German Democratic Republic) in 1963. In March 2008, Cephalon was approved by the U.S. Food and Drug Administration (FDA) to market this product in the United States for the treatment of chronic lymphocytic leukemia (CLL). In October 2008, the FDA approved Treanda for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) that progresses during or within six months of treatment with rituximab or rituximab containing regimen. Common side effects include cytopenia, fever, nausea, diarrhea, loss of appetite, cough, and rash. Other serious side effects include allergic reactions and an increased risk of infection.

Keyword:

Bendamustine

treatment

Scan the QR code to read on your phone